24-Valent Pneumococcal Conjugate Vaccine

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older AdultsNCT05297578PCVXPhase 2Completed2023-02-15Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.